We have qualitatively reviewed this strategy and reaffirmed its Process and People ratings. Primecap Odyssey Aggressive Growth stands out for its seasoned management and high-conviction multimanager system. The remainder of this analysis is from July 3, 2023.
PRIMECAP Odyssey Aggressive Growth POAGX
- NAV / 1-Day Return 45.89 / 0.00
- Total Assets 7.1 Bil
-
Adj. Expense Ratio
- Expense Ratio 0.660%
- Distribution Fee Level Low
- Share Class Type No Load
- Category Mid-Cap Growth
- Investment Style Mid Growth
- Min. Initial Investment 2,000
- Status Open
- TTM Yield 0.02%
- Turnover 5%
USD | NAV as of Jul 05, 2024 | 1-Day Return as of Jul 05, 2024, 10:18 PM GMT+0
Morningstar’s Analysis POAGX
Will POAGX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 29.8
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Eli Lilly and Co | 6.35 | 457.7 Mil | Healthcare |
Dreyfus Treasury Secs Cash Mgmt Inst | 5.31 | 383.1 Mil | Corporate |
Micron Technology Inc | 4.78 | 344.6 Mil | Technology |
Rhythm Pharmaceuticals Inc | 3.10 | 223.8 Mil | Healthcare |
Biogen Inc | 2.64 | 190.4 Mil | Healthcare |
Sony Group Corp ADR | 2.46 | 177.4 Mil | Technology |
Biomarin Pharmaceutical Inc | 2.36 | 170.0 Mil | Healthcare |
Flex Ltd | 2.30 | 165.6 Mil | Technology |
AECOM | 2.17 | 156.8 Mil | Industrials |
Jacobs Solutions Inc | 1.80 | 129.9 Mil | Industrials |